Literature DB >> 27050914

Invasive central nervous system aspergillosis in a patient with Crohn's disease after treatment with infliximab and corticosteroids.

Emma-Lee Bourne1, James Dimou2.   

Abstract

Aspergillus species are emerging as a significant cause of pneumonia mortality in immune compromised hosts, with haematological spread being a rare and life-threatening complication. The central nervous system (CNS) as a site for extrapulmonary spread is rarer still. We report a case of CNS disseminated aspergillosis in a patient treated with corticosteroids and infliximab, an immunomodulatory agent commonly used in the treatment of inflammatory bowel disease, and review the available literature regarding this rare pathology. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aspergillus; Central nervous system; Immunocompromised; Infliximab; Pneumonia

Mesh:

Substances:

Year:  2016        PMID: 27050914     DOI: 10.1016/j.jocn.2016.02.009

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

Review 1.  COVID-19-associated opportunistic infections: a snapshot on the current reports.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi
Journal:  Clin Exp Med       Date:  2021-08-23       Impact factor: 5.057

Review 2.  Neuroinfections caused by fungi.

Authors:  Katarzyna Góralska; Joanna Blaszkowska; Magdalena Dzikowiec
Journal:  Infection       Date:  2018-05-21       Impact factor: 3.553

3.  Granulomatous response to invasive pulmonary aspergillosis in an immunotherapy-naive host, a maladaptive response?

Authors:  Andres L Mora Carpio; Jessica M Stempel; Daniela de Lima Corvino; Veronica Garvia; Antonette Climaco
Journal:  Respir Med Case Rep       Date:  2018-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.